Covered recipient · General Payments record
JOHN OPRYSKO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$541.49
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $473.77 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $194.29 | 12 |
| Novo Nordisk AS | $60.40 | 3 |
| Exact Sciences Corporation | $59.26 | 4 |
| Astellas Pharma US Inc | $44.31 | 2 |
| DEXCOM, INC. | $41.82 | 2 |
| Lilly USA, LLC | $32.36 | 2 |
| Actelion Pharmaceuticals US, Inc. | $20.75 | 1 |
| Alvogen Inc | $20.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.34 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156629 | CMS |
| ABBVIE INC. | $19.31 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156631 | CMS |
| ABBVIE INC. | $30.35 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156633 | CMS |
| ABBVIE INC. | $3.10 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156635 | CMS |
| ABBVIE INC. | $15.54 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156637 | CMS |
| ABBVIE INC. | $14.10 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156639 | CMS |
| ABBVIE INC. | $6.30 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156641 | CMS |
| ABBVIE INC. | $20.53 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156643 | CMS |
| ABBVIE INC. | $16.00 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156645 | CMS |
| ABBVIE INC. | $15.33 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156647 | CMS |
| ABBVIE INC. | $17.01 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156649 | CMS |
| ABBVIE INC. | $33.38 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105156651 | CMS |
| Actelion Pharmaceuticals US, Inc. | $20.75 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078884693 | CMS |
| Alvogen Inc | $20.58 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137625223 | CMS |
| Astellas Pharma US Inc | $19.55 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139266408 | CMS |
| Astellas Pharma US Inc | $24.76 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428266 | CMS |
| Dexcom, Inc. | $18.85 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153309975 | CMS |
| Dexcom, Inc. | $22.97 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153309977 | CMS |
| Exact Sciences Corporation | $14.17 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114817236 | CMS |
| Exact Sciences Corporation | $15.69 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114817241 | CMS |
| Exact Sciences Corporation | $15.51 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114817247 | CMS |
| Exact Sciences Corporation | $13.89 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114817255 | CMS |
| Lilly USA, LLC | $14.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135058648 | CMS |
| Lilly USA, LLC | $17.69 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135069675 | CMS |
| Novo Nordisk Inc | $14.99 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097615178 | CMS |
| Novo Nordisk Inc | $21.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096847410 | CMS |
| Novo Nordisk Inc | $23.82 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097614337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.